Cardiovascular Innovations and Applications

Cardiovascular Innovations and Applications A platinum open access & the official journal of the Great Wall International Congress of Cardiology

Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicabili

ty in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. CVIA also welcomes commentaries, case studies and reports, letters to the editor, methodology papers related to clinical trials, education and training articles, techniques and videos. CVIA was founded on the occasion of the 25th anniversary of the GW-ICC in 2014 by Professor Dayi Hu, president of the GW-ICC and past president of the Chinese Society of Cardiology, and C. Richard Conti, MD, a past president of the American College of Cardiology and former Editor of Clinical Cardiology. The GW-ICC is one of the largest congresses in the Asian-Pacific region and is the most comprehensive and influential academic conference on cardiology. Held as a regular annual conference since 1990, GW-ICC has provided a platform for continuing education in cardiovascular disease diagnosis, treatment, and technology training, through events that leverage the expertise of internationally renowned cardiologists and scholars from the United States, Europe and Asia. The journal is published by Compuscript on behalf of the World Journals (Beijing) Medical Technology Co., Ltd. Compuscript is an international company based in Shannon, Ireland.

This case study illustrates the complexity of managing severe mitral regurgitation in an older patient with multiple com...
24/07/2025

This case study illustrates the complexity of managing severe mitral regurgitation in an older patient with multiple comorbidities, and highlights the successful outcome of the percutaneous with the .

:

First Italian case of percutaneous mitral valve repair with PASCAL Ace system in an elderly patient with a dislocated annuloplasty ring and severe regurgitation

This review summarizes the various   factors contributing to the etiology of different   (HF) types, current anti-inflam...
17/07/2025

This review summarizes the various factors contributing to the etiology of different (HF) types, current anti-inflammation therapies for HF, and lists the results of of anti-Inflammatory therapies in HF patients.

:

Explore the role of inflammation in heart failure, its impact on prognosis, and current therapeutic strategies to improve clinical outcomes in HF management.

This study used a   approach to provide a comprehensive understanding of the   and molecular mechanisms underlying   and...
17/07/2025

This study used a approach to provide a comprehensive understanding of the and molecular mechanisms underlying and (AAA), underscoring the importance of COPD as a potential risk factor for AAA.

:

A multi-omics approach for comprehensive understanding of the genetic and molecular mechanisms underlying COPD and Abdominal Aortic Aneurysm

This single-arm   demonstrates the feasibility of using a large-diameter   retrieving device for large-diameter thrombus...
10/07/2025

This single-arm demonstrates the feasibility of using a large-diameter retrieving device for large-diameter thrombus aspiration (16 f or greater) and mechanical in patients with .

:

Clinical trial on pulmonary embolism treatment using a large-diameter thrombus device shows promise for intermediate-risk acute pulmonary embolism treatment.

This study presents the case of a 54 year old woman with the   who underwent successful  , highlighting the importance o...
03/07/2025

This study presents the case of a 54 year old woman with the who underwent successful , highlighting the importance of advanced like TEE and CT in detecting anomalies.

:

This article discusses the diagnosis of quadricuspid aortic valve (QAV), highlighting a common presentation - detection in midlife following symptoms of severe regurgitation confirmed by transthoracic echocardiography (TTE). The delayed diagnosis underscores how valve dysfunction often emerges later...

This study developed and validated a predictive   incorporating NOAF and other clinical variables to improve risk strati...
01/07/2025

This study developed and validated a predictive incorporating NOAF and other clinical variables to improve risk stratification after cardiac resynchronization therapy (CRT) in patients with .

:

Heart failure (HF) with reduced ejection fraction (HFrEF; LVEF ≤ 35%) affects more than 64 million people globally. The 5-year all-cause mortality exceeds 40% among this population [1]. CRT is a cornerstone treatment for patients with HFrEF with left bundle branch block, prolonged QRS complex dura...

A comprehensive review on the mechanisms underlying reentrant supraventricular   (SVTs) and the effect of abnormal embry...
26/06/2025

A comprehensive review on the mechanisms underlying reentrant supraventricular (SVTs) and the effect of abnormal embryological development on reentrant SVTs in .


:

Reentrant supraventricular tachycardias (SVTs) in cc-TGA patients often involve complex reentrant circuits, including twin AV nodes and multiple accessory pathways

Happy to announce that CVIA has received an improved   of 1.4!We thank the editors, reviewers, authors, and readers!Publ...
20/06/2025

Happy to announce that CVIA has received an improved of 1.4!

We thank the editors, reviewers, authors, and readers!

Publish your research with CVIA

: https://cvia-journal.org/

This research letter discusses about the optimal timing and   for managing patients with aortic annular involvement due ...
19/06/2025

This research letter discusses about the optimal timing and for managing patients with aortic annular involvement due to .

:

Infective endocarditis (IE) is a serious infection caused by pathogenic bacteria that travel through the bloodstream and colonize the endocardium, thus resulting in rapid progression, numerous complications, and high mortality. Despite the emergence of new diagnostic and therapeutic strategies, the....

CVIA is proud to announce that the journal's   has increased to 1.2 this year!This demonstrates the growing impact our j...
19/06/2025

CVIA is proud to announce that the journal's has increased to 1.2 this year!

This demonstrates the growing impact our journal has in .

We thank our authors, reviewers, and editorial board.

: https://cvia-journal.org/

This clinical study compares the effectiveness of median   and right   for the removal of   and suggests right anterior ...
12/06/2025

This clinical study compares the effectiveness of median and right for the removal of and suggests right anterior minithoracotomy as a safe and effective alternative. GVM Care & Research

:

Comparing sternotomy with right mini-thoracotomy for the removal of cardiac myxomas- a clinical study.

This short commentary summarizes the pathophysiological and therapeutic role of major chemokines in  , a common Cardiac ...
12/06/2025

This short commentary summarizes the pathophysiological and therapeutic role of major chemokines in , a common Cardiac Arrhythmia condition.

: https://tinyurl.com/28cdnmo9

LCWU Lahore College for Women University

Chemokines are a subclass of cytokines, a large family of small secreted proteins that communicate via G protein-coupled heptahelical chemokine receptors on the cell surface. Atrial fibrillation (AF) is the most prevalent clinically relevant cardiac rhythm condition. Patients with persistent AF have...

Address

Shannon

Alerts

Be the first to know and let us send you an email when Cardiovascular Innovations and Applications posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cardiovascular Innovations and Applications:

Share

Category

Our Story

Cardiovascular Innovations and Applications (CVIA) was founded on the occasion of the 25th anniversary of the GW-ICC in 2014 by Professor Dayi Hu, president of the GW-ICC and past president of the Chinese Society of Cardiology, who will serve as Founding Editor. C. Richard Conti, MD, a past president of the American College of Cardiology and former Editor of Clinical Cardiology, has recently been appointed Editor-in-Chief of the new journal, which will publish its first issue to coincide with the GW-ICC meeting in October 2015 in Beijing, China.